Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Onconetix (ONCO) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to 2945.97%.

  • Onconetix's EBITDA Margin fell 28388300.0% to 2945.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 4143.0%, marking a year-over-year decrease of 10270400.0%. This contributed to the annual value of 2527.43% for FY2024, which is 573866600.0% up from last year.
  • Onconetix's EBITDA Margin amounted to 2945.97% in Q3 2025, which was down 28388300.0% from 135.84% recorded in Q2 2025.
  • In the past 5 years, Onconetix's EBITDA Margin ranged from a high of 10592.34% in Q4 2023 and a low of 8300.32% during Q1 2025
  • In the last 3 years, Onconetix's EBITDA Margin had a median value of 1077.36% in 2024 and averaged 465.81%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -152518100bps in 2024, then skyrocketed by 18830500bps in 2025.
  • Over the past 3 years, Onconetix's EBITDA Margin (Quarter) stood at 10592.34% in 2023, then plummeted by -144bps to 4659.47% in 2024, then surged by 37bps to 2945.97% in 2025.
  • Its last three reported values are 2945.97% in Q3 2025, 135.84% for Q2 2025, and 8300.32% during Q1 2025.